Capital Advisors Inc. OK raised its stake in CVS Health Co. (NYSE:CVS – Get Rating) by 3.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,360 shares of the pharmacy operator's stock after purchasing an additional 426 shares during the period. Capital Advisors Inc. OK's holdings in CVS Health were worth $1,331,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Arlington Partners LLC increased its position in shares of CVS Health by 23.4% during the first quarter. Arlington Partners LLC now owns 528 shares of the pharmacy operator's stock worth $53,000 after acquiring an additional 100 shares in the last quarter. Wiley BROS. Aintree Capital LLC grew its position in CVS Health by 4.6% in the 1st quarter. Wiley BROS. Aintree Capital LLC now owns 2,265 shares of the pharmacy operator's stock worth $229,000 after purchasing an additional 100 shares in the last quarter. Palladium Partners LLC grew its position in CVS Health by 2.8% in the 1st quarter. Palladium Partners LLC now owns 3,687 shares of the pharmacy operator's stock worth $373,000 after purchasing an additional 100 shares in the last quarter. Tortoise Investment Management LLC grew its position in CVS Health by 6.6% in the 1st quarter. Tortoise Investment Management LLC now owns 1,612 shares of the pharmacy operator's stock worth $163,000 after purchasing an additional 100 shares in the last quarter. Finally, Keudell Morrison Wealth Management grew its position in CVS Health by 3.2% in the 1st quarter. Keudell Morrison Wealth Management now owns 3,266 shares of the pharmacy operator's stock worth $331,000 after purchasing an additional 102 shares in the last quarter. 77.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other CVS Health news, EVP Alan Lotvin sold 22,541 shares of CVS Health stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the completion of the sale, the executive vice president now owns 109,183 shares of the company's stock, valued at $11,355,032. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other CVS Health news, EVP Alan Lotvin sold 22,541 shares of CVS Health stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the completion of the sale, the executive vice president now owns 109,183 shares of the company's stock, valued at $11,355,032. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Thomas M. Moriarty sold 138,654 shares of CVS Health stock in a transaction dated Tuesday, June 28th. The stock was sold at an average price of $95.00, for a total value of $13,172,130.00. Following the sale, the executive vice president now directly owns 626,273 shares of the company's stock, valued at approximately $59,495,935. The disclosure for this sale can be found here. Corporate insiders own 0.69% of the company's stock.

CVS Health Stock Performance

CVS Health (NYSE:CVS – Get Rating) last posted its earnings results on Wednesday, August 3rd. The pharmacy operator reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.16 by $0.24. CVS Health had a net margin of 2.65% and a return on equity of 15.19%. The business had revenue of $80.64 billion for the quarter, compared to analysts' expectations of $76.38 billion. During the same period in the prior year, the company posted $2.42 EPS. The business's revenue for the quarter was up 11.0% compared to the same quarter last year. Analysts predict that CVS Health Co. will post 8.53 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, November 1st. Shareholders of record on Friday, October 21st will be paid a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 2.24%. The ex-dividend date of this dividend is Thursday, October 20th. CVS Health's dividend payout ratio (DPR) is currently 35.77%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft upped their price objective on shares of CVS Health from $113.00 to $120.00 in a research report on Thursday, August 4th. Credit Suisse Group boosted their target price on shares of CVS Health from $113.00 to $117.00 and gave the company an "outperform" rating in a research note on Monday, August 8th. Evercore ISI boosted their target price on shares of CVS Health from $120.00 to $125.00 and gave the company an "outperform" rating in a research note on Wednesday, September 7th. Mizuho boosted their target price on shares of CVS Health from $115.00 to $120.00 and gave the company a "buy" rating in a research note on Monday, August 15th. Finally, Loop Capital initiated coverage on shares of CVS Health in a research note on Thursday, June 16th. They issued a "buy" rating and a $120.00 target price on the stock. Four investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, CVS Health presently has a consensus rating of "Moderate Buy" and an average target price of $117.59.

CVS Health Profile

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Read More

• Get a free copy of the StockNews.com research report on CVS Health (CVS)
• Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
• MarketBeat: Week in Review 9/19 – 9/23
• Why Does Tesla Stock Remain Resilient?
• 2 Semiconductor Stocks To Watch For Reversals
• Is Costco's Post-Earnings Price Weakness A Good Time To Buy?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Get Rating).

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.